This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_BLADDER_EXALLC for full statistics.
Malignant neoplasm of bladder
C3_BLADDER
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2855 |
4. Check minimum number of eventsNone |
2855 |
5. Include endpointsNone |
2855 |
6. Filter based on genotype QC (FinnGen only) |
2855 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bladder
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2855 | 456 | 2399 |
| Unadjusted period prevalence (%) | 0.91 | 0.16 | 1.06 |
| Median age at first event (years) | 70.64 | 67.99 | 71.15 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2683
- Matched controls
- 26828
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
224.7
323.0
418
22
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
264.2
323.0
1716
179
R31
ICD-10 Finland
Unspecified haematuria
9.7
323.0
1311
2414
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
12869.3
323.0
2064
5
KCD02
NOMESCO Finland
Transurethral resection of bladder
342.1
323.0
2008
233
UKC02
NOMESCO Finland
Cystoscopy
38.2
323.0
2332
3973
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
297.3
323.0
1440
104
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
73.1
323.0
980
209
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
82.5
323.0
671
108
KCC10
NOMESCO Finland
Cystoprostatectomy
342.5
323.0
406
14
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
154.9
323.0
782
71
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
58.0
323.0
502
106
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
290.6
308.2
309
12
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
32.6
288.1
385
137
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
116.8
279.8
301
29
ZX136
NOMESCO Finland
Intravesicalis
54.7
267.0
319
66
8130/3-C67.9
ICD-O-3
Papillary urothelial carcinoma of bladder, NOS
+∞
216.6
205
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
416.9
196.7
195
5
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
146.2
192.3
203
15
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
25.1
184.3
264
116
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
820.0
159.2
155
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
26.5
159.0
224
92
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
402.1
153.8
153
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
104.0
152.0
166
17
J01MA02
ATC
ciprofloxacin; systemic
2.9
151.4
1518
8234
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.7
149.7
473
966
KCB00
NOMESCO Finland
Biopsy of bladder
73.0
144.6
165
24
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
11.8
143.1
275
257
7323
FHL
Electrosection of TU bladder wall change
187.2
136.9
142
8
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
14.7
135.7
235
174
J01EA01
ATC
trimethoprim; systemic
3.2
131.3
892
3631
U76
ICPC
Malignant neoplasm of bladder
110.9
126.3
137
13
130
Kela drug reimbursment
Malignant tumour
4.0
123.1
572
1712
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.4
122.6
704
2510
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
1210.1
119.7
116
*
KCW96
NOMESCO Finland
Other operations on bladder
29.0
110.3
151
55
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
20.0
110.2
169
90
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
1058.1
105.0
102
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.3
103.0
617
2233
TKC20
NOMESCO Finland
Catheterisation of bladder
3.7
99.9
496
1546
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
26.1
98.8
139
56
8120/3-C67.2
ICD-O-3
Transitional cell carcinoma, NOS, of lateral wall of bladder
993.4
98.7
96
*
WX320
NOMESCO Finland
Spinalanesthesy
2.7
96.4
827
3772
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.4
96.3
222
285
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
93.8
875
4178
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
17.7
91.4
146
87
7321
FHL
TU biopsy, coagulation or laser
34.9
87.5
114
34
U06
ICPC
Haematuria
6.7
84.3
227
366
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
8.1
83.6
197
261
TJF80
NOMESCO Finland
Ostomy education
16.6
83.2
136
86
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
28.3
79.4
109
40
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
38.5
73.0
93
25
XKD00
NOMESCO Finland
Uroflowmetry
2.3
71.4
890
4794
KA3EB
NOMESCO Finland
Antegrade pyelography
27.1
70.0
97
37
A04AD12
ATC
aprepitant; systemic
12.3
69.0
128
109
B02AA02
ATC
tranexamic acid; systemic
3.4
68.4
366
1185
JN4AD
NOMESCO Finland
Body CT examination
3.5
68.3
359
1147
KCD30
NOMESCO Finland
Destruction of tumour of bladder
124.9
68.2
73
6
JN4BD
NOMESCO Finland
Extensive body CT
2.9
67.4
473
1851
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
64.7
642
3063
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.0
64.1
278
754
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
200.9
57.2
59
*
JEA00
NOMESCO Finland
Appendectomy
4.4
56.6
218
528
B01AB10
ATC
tinzaparin; parenteral
3.6
55.9
273
817
KA1FN
NOMESCO Finland
Isotope renography
18.3
55.6
87
49
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.2
55.5
668
3465
KC1GB
NOMESCO Finland
Cystography with X-ray
10.5
54.6
109
108
JN4CD
NOMESCO Finland
Very extensive body CT
4.3
54.4
217
543
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
145.4
54.0
57
*
KDV10
NOMESCO Finland
Internal urethrotomy
6.2
53.1
149
252
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
98.7
53.0
58
6
1530
FHL
Urethrocystoscopy
4.8
51.2
181
401
J01MA12
ATC
levofloxacin; systemic
2.1
51.2
700
3820
H02AB02
ATC
dexamethasone; systemic
2.9
51.1
350
1332
UKB02
NOMESCO Finland
Retrograde ureteroscopy
9.0
50.4
109
125
8000/3-C67.9
ICD-O-3
Neoplasm, malignant of bladder, NOS
+∞
50.1
48
*
A04AA02
ATC
granisetron; systemic, transdermal
3.8
49.8
226
634
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.2
49.4
138
232
KH1AD
NOMESCO Finland
CT of urinary organs
5.0
49.1
164
342
1889X
ICD-9 Finland
Malignant neoplasm of bladder, Bladder, part unspecified
132.4
48.9
52
*
N30.0
ICD-10 Finland
Acute cystitis
2.7
48.8
382
1572
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.4
45.7
429
1948
C66
ICD-10 Finland
Malignant neoplasm of ureter
26.8
45.6
63
24
J01CA08
ATC
pivmecillinam; oral
2.1
44.6
595
3186
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
8.1
44.6
103
132
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
63.6
43.3
50
8
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
18.8
42.8
66
36
Z51.5
ICD-10 Finland
Palliative care
2.8
42.2
294
1124
R33
ICD-10 Finland
Retention of urine
2.3
42.1
468
2301
JN3AD
NOMESCO Finland
Abdominal CT examination
2.9
40.7
274
1023
ZXC20
NOMESCO Finland
Use of chemical agents
4.5
39.0
144
333
XKD10
NOMESCO Finland
Transurethral ultrasonography
74.6
39.0
44
6
B01AB05
ATC
enoxaparin; parenteral
1.8
38.7
837
5329
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
38.4
198
614
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.7
38.3
178
508
18899
ICD-8 Finland
Malignant neoplasm of bladder
104.0
37.8
41
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
20.4
37.5
56
28
WX224
NOMESCO Finland
Blockade of obturius nerve
55.8
37.4
44
8
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.6
37.1
177
516
KCC00
NOMESCO Finland
Cystectomy
372.2
37.1
37
*
4CX01
NOMESCO Finland
NA
70.9
37.0
42
6
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
36.9
472
2459
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
35.5
1220
8891
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
18.1
35.4
55
31
KWA00
NOMESCO Finland
Repair of wound dehiscence in urological surgery
182.3
34.8
36
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
34.4
736
4635
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
34.1
329
1503
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
177.1
33.8
35
*
N02AA05
ATC
oxycodone; systemic
1.9
32.6
532
3037
N30.9
ICD-10 Finland
Cystitis, unspecified
3.1
32.6
185
616
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
14.9
32.3
54
37
SPAT1125
SPAT
Stoma care and guidance
4.8
31.2
106
226
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
30.9
360
1789
KBV00
NOMESCO Finland
Insertion of stent into ureter
11.6
30.6
57
50
WZC30
NOMESCO Finland
Teaching
2.2
30.0
352
1754
WF049
NOMESCO Finland
Radiotherapy of metastasis
3.6
29.9
141
408
A04AA01
ATC
ondansetron; systemic, rectal
2.9
29.5
186
664
A04AA55
ATC
palonosetron, combinations; systemic
6.7
29.2
76
117
8120/3-C67.4
ICD-O-3
Transitional cell carcinoma, NOS, of posterior wall of bladder
+∞
29.2
28
*
8120/3-C67.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of bladder
+∞
29.2
28
*
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
19.4
29.1
44
23
U99
ICPC
Urinary disease other
7.8
28.7
67
88
KBJ80
NOMESCO Finland
Operation for malfunction of urinary diversion
151.5
28.7
30
*
WX402
NOMESCO Finland
General anaesthesia
2.1
28.4
339
1699
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
7.3
28.0
68
95
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
27.5
28.0
38
14
N02BE01
ATC
paracetamol; systemic, rectal
1.7
27.7
2041
17636
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.0
27.7
418
2305
J01DB01
ATC
cefalexin; oral
1.6
27.5
1858
15668
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.2
27.1
150
491
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
12.9
26.6
47
37
WF004
NOMESCO Finland
Palliative radiotherapy
4.2
25.8
101
249
KAC20
NOMESCO Finland
Nephroureterectomy
17.6
25.7
40
23
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
94.3
25.7
28
*
SPAT1262
SPAT
Handing over of treatment supplies
1.8
25.7
545
3374
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
22.0
25.6
37
17
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.6
25.6
121
351
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
3.3
25.5
133
417
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.9
25.1
107
285
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
25.0
24
*
WX882
NOMESCO Finland
High dependency care
3.4
25.0
126
385
C67.7
ICD-10 Finland
Malignant neoplasm: Urachus
131.2
24.6
26
*
KED22
NOMESCO Finland
Transurethral resection of prostate
1.9
23.1
355
1960
U07
ICPC
Urine symptom/complaint other
2.6
23.0
179
726
UKD02
NOMESCO Finland
Urethroscopy
8.0
22.9
52
66
U28
ICPC
Limited function/disability (U)
5.0
22.7
74
152
J01MA01
ATC
ofloxacin; systemic
2.0
22.2
308
1636
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
80.7
21.7
24
*
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
3.8
21.3
91
244
XX3DW
NOMESCO Finland
Time consuming IT work
2.0
20.9
268
1377
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
20.9
555
3647
8120/3-C67.6
ICD-O-3
Transitional cell carcinoma, NOS, of ureteric orifice
+∞
20.9
20
*
3AX03
NOMESCO Finland
NA
211.4
20.6
21
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.3
20.3
195
880
G04CA02
ATC
tamsulosin; oral
1.5
19.8
1100
8586
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.6
19.5
88
247
KH1CB
NOMESCO Finland
Urography with X-ray
24.8
19.5
27
11
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
6.5
19.3
50
78
ZXC15
NOMESCO Finland
Use of photodynamic technique
4.0
19.2
78
200
U29
ICPC
Urinary symptom/complaint other
3.3
19.2
99
309
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
7.4
19.0
45
62
8120/3-C67.1
ICD-O-3
Transitional cell carcinoma, NOS, of dome of bladder
+∞
18.8
18
*
8120/3-C67.5
ICD-O-3
Transitional cell carcinoma, NOS, of bladder neck
+∞
18.8
18
*
N13.1
ICD-10 Finland
Hydronephrosis with ureteral stricture, not elsewhere classified
10.7
17.9
34
32
KBH20
NOMESCO Finland
Replantation of ureter
26.9
17.8
24
9
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.6
17.5
497
3304
KA3GB
NOMESCO Finland
Retrograde pyelography
21.0
17.3
25
12
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.6
17.2
481
3182
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
3.1
17.1
94
309
G04BD08
ATC
solifenacin; oral
2.0
17.0
214
1092
J01MA06
ATC
norfloxacin; oral
1.8
16.9
309
1806
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
9.5
16.9
34
36
7343
FHL
Cystectomy and enterocystoplasty
+∞
16.7
16
*
UKC22
NOMESCO Finland
Urethroneocystoscopy
+∞
16.7
16
*
KBD00
NOMESCO Finland
Partial excision of ureter
35.2
16.7
21
6
WC135
NOMESCO Finland
Very demanding cytostatic therapy of local tumor recidive
90.6
16.6
18
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.8
16.4
69
184
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
3.7
16.3
72
200
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
16.2
613
4363
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
47.8
16.0
19
*
U05
ICPC
Urination problems other
2.2
15.7
158
732
N13.9
ICD-10 Finland
Obstructive and reflux uropathy, unspecified
7.9
15.6
35
45
Z93
ICD-10 Finland
Artificial opening status
11.8
15.5
28
24
Z93.6
ICD-10 Finland
Other artificial openings of urinary tract status
16.1
15.2
24
15
KWW96
NOMESCO Finland
Other reoperation in urological surgery
45.2
15.1
18
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
4.1
14.9
58
145
SPAT1167
SPAT
Insertion of urinary catheter
2.2
14.8
146
669
KCJ10
NOMESCO Finland
Cutaneous cystoenterostomy
+∞
14.6
14
*
KCH10
NOMESCO Finland
Enterocystoplasty
+∞
14.6
14
*
U70
ICPC
Pyelonephritis/pyelitis
5.0
14.6
46
93
U13
ICPC
Bladder symptom/complaint other
3.0
14.5
83
279
U14
ICPC
Kidney symptom/complaint
3.9
14.4
59
154
4078
NOMESCO Finland
NA
53.6
13.8
16
*
1880A
ICD-9 Finland
Malignant neoplasm of bladder, Trigone of urinary bladder
+∞
13.5
13
*
KDC00
NOMESCO Finland
Urethrectomy
140.6
13.5
14
*
KH1RT
NOMESCO Finland
Urinary tract dilatatation with radiological guidance
140.6
13.5
14
*
KBV10
NOMESCO Finland
Removal of stent from ureter
5.7
13.1
37
66
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
13.1
118
519
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.3
13.1
121
540
J01CA04
ATC
amoxicillin; systemic
1.4
12.9
1657
14568
KCV02
NOMESCO Finland
Cystoscopic balloon distension of bladder
70.2
12.6
14
*
2394A
ICD-9 Finland
Neoplasm of unspecified nature, Bladder
32.2
12.6
16
5
N02AX02
ATC
tramadol; systemic, rectal
1.4
12.5
1004
8172
N13.0
ICD-10 Finland
Hydronephrosis with ureteropelvic junction obstruction
6.1
12.4
33
55
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
3.2
12.3
64
204
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
12.3
251
1515
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
15.9
12.1
19
12
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
12.1
72
252
G04BD12
ATC
mirabegron; oral
1.7
12.1
267
1649
7326
FHL
Bladder lavage
11.1
12.0
22
20
KCD10
NOMESCO Finland
Partial cystectomy
21.4
12.0
17
8
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
3.0
11.7
67
227
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
11.7
167
896
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.1
11.6
61
197
GD1AD
NOMESCO Finland
Thorax CT examination
2.2
11.5
118
551
8140/3-C67.9
ICD-O-3
Adenocarcinoma, NOS, of bladder, NOS
+∞
11.5
11
*
A06AH03
ATC
naloxegol; oral
4.1
11.4
43
106
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
11.3
921
7481
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
11.3
144
739
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.4
11.3
90
375
7339
FHL
Other measure in this category
25.1
11.1
15
6
A41.8
ICD-10 Finland
Other specified sepsis
2.9
11.1
66
232
R50.9
ICD-10 Finland
Fever, unspecified
1.5
10.9
342
2311
SPAT1168
SPAT
Catheterisation training
5.0
10.9
34
69
JAG41
NOMESCO Finland
Repair of stomal hernia, laparoscopic
60.2
10.6
12
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.5
10.6
81
329
N99.5
ICD-10 Finland
Malfunction of external stoma of urinary tract
11.2
10.5
19
17
U77
ICPC
Malignant neopl urinary tract other
6.5
10.5
26
40
N02
ICD-10 Finland
Recurrent and persistent haematuria
14.2
10.5
17
12
KDW98
NOMESCO Finland
Other transluminal endoscopic operations on urethra
110.4
10.4
11
*
8041/3-C67.9
ICD-O-3
Small cell carcinoma, NOS, of bladder, NOS
+∞
10.4
10
*
Z93.5
ICD-10 Finland
Cystostomy status
7.7
10.4
23
30
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.5
10.3
445
3223
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
3.5
10.3
46
132
U02
ICPC
Urinary frequency/urgency
1.7
10.3
214
1300
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
10.2
235
1470
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.4
10.2
85
361
KH1DD
NOMESCO Finland
CT urography of urinary organs
13.1
10.1
17
13
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
9.1
10.0
20
22
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.0
10.0
38
95
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.4
10.0
443
3224
JAH00
NOMESCO Finland
Laparotomy
2.3
9.9
87
382
WW500
NOMESCO Finland
Blood transfusion
2.1
9.8
113
558
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
26.1
9.8
13
5
N21.0
ICD-10 Finland
Calculus in bladder
3.0
9.8
54
182
U71
ICPC
Cystitis/urinary infection other
2.2
9.6
92
419
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.6
9.5
66
256
U04
ICPC
Incontinence urine
2.0
9.4
113
570
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
30.1
9.4
12
*
1544
FHL
Urinary tract endoscopy
17.6
9.4
14
8
8120/3-C67.0
ICD-O-3
Transitional cell carcinoma, NOS, of trigone of bladder
+∞
9.4
9
*
U79
ICPC
Neoplasm urinary tract unspecified
13.7
9.2
15
11
R4110
NOMESCO Finland
Physiotherapy
1.4
9.1
562
4335
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
8.9
653
5179
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
8.9
186
1130
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.0
8.5
103
521
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
27.6
8.5
11
*
G04BE01
ATC
alprostadil; parenteral, urethral
2.1
8.4
92
447
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
12.8
8.4
14
11
N07BA03
ATC
varenicline; oral
2.4
8.3
65
270
8010/3-C67.9
ICD-O-3
Carcinoma, NOS, of bladder, NOS
+∞
8.3
8
*
KBJ00
NOMESCO Finland
Cutaneous ureterostomy
+∞
8.3
8
*
7342
FHL
Cystectomy and differential surgery
+∞
8.3
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
8.3
122
665
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.8
8.3
130
726
WB101
NOMESCO Finland
Simple cytostatic neoadjuvant therapy
14.5
8.2
13
9
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.4
8.1
67
288
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
13.0
7.9
13
10
TKC00
NOMESCO Finland
Needle biopsy of bladder
13.0
7.9
13
10
WX704
NOMESCO Finland
Intubation
1.8
7.8
135
778
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
7.8
188
1191
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
2.9
7.7
45
158
WX400
NOMESCO Finland
Inhalation anesthesy
2.3
7.7
69
307
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.2
7.6
76
355
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.8
7.6
45
161
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
7.6
221
1469
V03AE01
ATC
polystyrene sulfonate; oral
2.7
7.5
48
177
WB131
NOMESCO Finland
Very demanding neoadjuvant cytostatic therapy
80.3
7.4
8
*
A28
ICPC
Limited function/disability NOS
1.4
7.3
458
3536
8070/3-C67.9
ICD-O-3
Squamous cell carcinoma, NOS, of bladder, NOS
+∞
7.3
7
*
8130/3-C67.2
ICD-O-3
Papillary urothelial carcinoma of lateral wall of bladder
+∞
7.3
7
*
L03AA02
ATC
filgrastim; parenteral
2.3
7.3
66
296
WX110
NOMESCO Finland
Local anesthesy
1.2
7.2
1200
10547
G04AC01
ATC
NA
2.3
7.1
63
281
R03BB04
ATC
tiotropium bromide; inhalant
1.4
7.1
332
2440
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
3.9
7.0
27
70
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.2
7.0
67
308
PD1AD
NOMESCO Finland
CT of abdominal aorta and branches
4.3
7.0
24
56
U01
ICPC
Dysuria/painful urination
1.9
6.9
90
472
N30.8
ICD-10 Finland
Other cystitis
5.5
6.9
19
35
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.4
6.9
299
2162
KBB00
NOMESCO Finland
Biopsy of ureter
13.8
6.9
11
8
J01XE01
ATC
nitrofurantoin; oral
2.8
6.9
42
154
G04CA01
ATC
alfuzosin; oral
1.4
6.9
436
3368
KC1GD
NOMESCO Finland
CT cystography of bladder
40.1
6.8
8
*
KBH96
NOMESCO Finland
Other repair or connection of ureter
40.1
6.8
8
*
A18.1
ICD-10 Finland
Tuberculosis of genitourinary system
22.6
6.7
9
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
6.7
241
1680
KGH10
NOMESCO Finland
Operation for phimosis
2.0
6.7
81
414
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
1.9
6.7
93
498
A03
ICPC
Fever
1.5
6.6
199
1335
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.2
6.6
60
272
E87.5
ICD-10 Finland
Hyperkalaemia
2.3
6.5
58
260
Z72.0
ICD-10 Finland
Tobacco use
2.6
6.5
43
166
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
2.3
6.5
53
229
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
2.9
6.4
35
120
RD211
NOMESCO Finland
NA
1.9
6.4
83
435
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
1.5
6.4
184
1220
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
6.4
150
945
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
6.5
6.3
15
23
KC1AE
NOMESCO Finland
Percutaneous ultrasound examination of urinary bladder
6.5
6.3
15
23
Z43.6
ICD-10 Finland
Attention to other artificial openings of urinary tract
8.2
6.3
13
16
WX002
NOMESCO Finland
Sedation and analgesia
1.3
6.3
409
3169
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
18.0
6.3
9
5
KBC00
NOMESCO Finland
Ureterectomy
+∞
6.2
6
*
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
5.3
6.1
17
32
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.8
6.1
104
599
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
6.1
249
1780
JF1AD
NOMESCO Finland
Small bowel CT
4.9
6.0
18
37
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
2.7
6.0
39
147
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3049717) Cytology report of Urine Cyto stain
1318
1206
19.44
307.65
5.9
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1481
6520
3.64
251.50
6.1
3.3
—
—
—
0
0
(3002256) Pathology report gross observation
772
2692
3.56
179.24
1.7
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
1574
8440
2.93
170.87
8.7
3.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
717
3134
2.72
105.81
8.1
6.5
mmol/l
105.5
104.4
8.61
711
3039
(3000850) Epithelial cells [#/volume] in Urine
1000
5156
2.45
104.11
5.8
2.7
e6/l
5.1
3.6
3.09
933
4570
(3002582) Erythrocytes [#/volume] in Urine
1249
7208
2.30
99.21
9.5
3.5
e6/l
277.8
123.2
1.90
1114
5797
(3031040) Bacteria [#/volume] in Urine by Automated count
1931
13647
2.28
89.87
12.4
4.8
e6/l
1634.7
1852.8
0.06
34
297
(3018095) Leukocytes [#/volume] in Urine
1304
7927
2.19
88.27
10.3
3.9
e6/l
295.4
101.4
2.57
1154
6095
(40768804) Tissue Pathology biopsy report
1234
7408
2.17
85.49
3.1
2.3
—
—
—
0
0
(3026782) Osmolality of Urine
911
4875
2.28
83.65
6.5
2.9
mosm/kgh2o
557.0
567.9
1.04
827
4168
(3030467) Casts [#/volume] in Urine by Automated count
1104
6450
2.16
80.89
9.5
3.4
e6/l
0.5
0.5
0.47
987
5066
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1441
9373
2.08
78.86
5.8
4.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1060
6143
2.15
78.86
9.5
3.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1114
6660
2.10
75.65
3.4
2.7
—
—
—
0
0
(4035726)
424
1680
2.79
73.52
1.4
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
729
3738
2.28
72.61
9.1
3.2
e6/l
1.0
1.3
1.67
574
2215
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
748
3903
2.24
71.23
8.3
3.0
e6/l
2.1
1.1
4.93
589
2355
(3023368) Bacteria identified in Blood by Culture
1181
7492
1.98
65.63
5.5
4.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
410
1704
2.64
64.24
5.3
3.7
mmol/l
0.2
1.9
12.03
314
1207
(3009343) pH of Capillary blood
420
1770
2.61
63.96
5.4
3.8
ph
7.4
7.4
0.01
41
217
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
422
1792
2.59
63.23
5.5
3.8
kpa
5.0
5.1
3.58
404
1625
(3037467) Urinalysis macro (dipstick) panel - Urine
1850
13765
1.98
63.14
8.3
4.5
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
516
2477
2.32
58.78
5.1
3.6
kpa
5.9
5.8
1.72
505
2386
(3022313) Gas panel - Capillary blood
326
1260
2.79
58.65
5.6
4.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
513
2474
2.31
57.72
5.1
3.6
mmol/l
1.4
1.9
1.99
443
1925
(3000991) Gas panel - Venous blood
451
2106
2.36
54.46
9.9
7.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
275
1031
2.84
52.21
5.9
4.3
mmol/l
23.9
24.6
4.04
261
929
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
835
5074
1.91
49.66
3.2
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
411
1938
2.31
48.15
6.1
3.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
652
3693
1.99
47.42
4.8
3.0
mmol/l
0.8
0.8
4.93
612
3415
(3014111) Lactate [Moles/volume] in Serum or Plasma
433
2225
2.11
40.55
8.2
6.3
mmol/l
1.4
1.5
0.23
415
2116
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
276
1187
2.47
39.46
4.9
3.6
mmol/l
23.6
24.0
1.46
255
1047
(3020779) Urea [Moles/volume] in Serum or Plasma
451
2388
2.06
38.87
5.6
6.7
mmol/l
11.8
12.2
0.50
421
2238
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1461
11112
1.64
36.30
8.2
6.1
umol/l
10.8
13.1
7.11
1406
10518
(3009261) Glucose [Presence] in Urine by Test strip
1291
9592
1.63
34.67
6.2
3.9
estimate
0.0
0.0
0.50
267
1779
(3035350) Ketones [Presence] in Urine by Test strip
1275
9477
1.62
33.95
6.1
3.9
estimate
0.0
0.0
0.00
274
1836
(3003458) Phosphate [Moles/volume] in Serum or Plasma
544
3203
1.86
33.94
5.6
5.7
mmol/l
1.0
1.0
0.16
511
2933
(3021601) Nitrite [Presence] in Urine by Test strip
1267
9432
1.62
33.32
8.0
5.2
estimate
0.0
0.0
0.00
272
1852
(3030981) Hyaline casts [#/volume] in Urine by Automated count
306
1486
2.19
32.79
5.8
3.0
e6/l
0.8
0.3
2.07
301
1462
(3024561) Albumin [Mass/volume] in Serum or Plasma
1294
9716
1.61
32.61
5.8
4.8
g/l
32.5
34.1
14.31
1212
8885
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
314
1569
2.12
31.22
10.2
8.3
%
0.5
0.7
7.17
306
1556
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
514
3048
1.84
31.09
8.5
6.6
kpa
5.1
5.0
0.40
488
2870
(3027801) Oxygen [Partial pressure] in Arterial blood
514
3048
1.84
31.09
8.5
6.6
kpa
13.0
11.5
9.30
483
2872
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
314
1573
2.12
31.01
10.1
8.2
%
1.1
1.3
3.78
306
1561
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
282
1357
2.20
30.85
10.5
9.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
513
3049
1.83
30.77
8.5
6.6
mmol/l
-0.2
1.1
7.92
411
2302
(3016502) Oxygen saturation in Arterial blood
472
2761
1.85
29.72
9.0
6.8
%
96.3
95.0
6.32
457
2637
(3013826) Glucose [Moles/volume] in Serum or Plasma
1605
12892
1.56
28.77
6.9
5.0
mmol/l
7.0
7.0
0.17
1542
12172
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
283
1403
2.13
28.64
10.4
8.3
mmol/l
23.4
24.2
4.04
267
1284
(3002173) Hemoglobin [Mass/volume] in Arterial blood
423
2441
1.86
27.67
9.5
7.4
g/l
115.1
120.7
8.00
414
2352
(3013650) Neutrophils [#/volume] in Blood by Automated count
1413
11209
1.52
25.55
10.8
8.3
e9/l
4.8
4.5
4.02
1272
9692
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1297
10107
1.52
25.51
7.8
6.1
mmol/l
1.2
1.2
2.04
1185
9045
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
323
1750
1.95
25.50
1.6
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1305
10198
1.51
25.23
10.5
12.2
inr
1.3
1.4
5.22
309
2796
(40761539) Cells [Type] in Urine sediment by Light microscopy
40
63
6.42
24.36
1.3
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
150
626
2.47
22.74
4.0
4.1
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1385
11117
1.48
22.54
8.4
7.0
mmol/l
1.2
1.2
1.63
1172
9247
(3028626) Oxygen [Partial pressure] in Capillary blood
158
689
2.37
21.74
3.5
3.0
kpa
8.4
7.6
6.83
150
635
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
891
6609
1.51
21.11
3.4
2.5
u/l
62.2
59.1
0.43
843
6079
(3024354) Oxygen [Partial pressure] in Venous blood
347
2042
1.80
20.98
3.7
3.0
kpa
4.2
4.4
1.48
335
1957
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
208
1041
2.08
20.41
2.6
2.6
u/ml
0.4
0.3
0.39
104
607
(3027273) Bicarbonate [Moles/volume] in Venous blood
252
1355
1.94
20.21
5.1
3.5
mmol/l
24.6
24.9
0.56
247
1316
(3004119) Hemoglobin [Mass/volume] in Venous blood
281
1584
1.86
19.50
4.6
3.2
g/l
124.5
127.0
0.92
276
1551
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
276
1562
1.85
18.90
1.6
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
906
6907
1.46
18.10
5.6
5.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
165
798
2.13
17.71
4.2
3.2
mmol/l
23.3
24.8
4.49
153
689
(3015377) Calcium [Moles/volume] in Serum or Plasma
931
7181
1.44
17.30
4.5
3.3
mmol/l
2.3
2.3
1.15
795
6082
(3011397) Hemoglobin [Presence] in Urine by Test strip
627
4502
1.50
16.74
6.1
3.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1790
15544
1.41
16.45
10.4
7.6
u/l
88.2
83.0
2.37
1712
14493
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
946
7370
1.42
16.45
7.1
4.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1206
9850
1.39
15.73
5.8
5.4
e9/l
1.8
1.9
0.55
1037
8508
(3006315) Basophils [#/volume] in Blood
1190
9709
1.39
15.57
5.6
5.3
e9/l
0.0
0.0
0.13
1015
8259
(3019069) Monocytes/100 leukocytes in Blood
1137
9207
1.39
15.57
6.1
5.9
%
9.1
9.1
0.07
1073
8513
(3006504) Eosinophils/100 leukocytes in Blood
1132
9163
1.39
15.52
5.9
5.6
%
2.7
2.9
1.39
1066
8453
(3002030) Lymphocytes/100 leukocytes in Blood
1151
9343
1.39
15.52
6.1
5.8
%
23.1
24.8
5.73
1082
8573
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
327
2054
1.67
15.47
2.4
2.1
g/l
0.2
0.2
1.45
303
1874
(3013115) Eosinophils [#/volume] in Blood
1218
9988
1.38
15.40
5.8
5.5
e9/l
0.2
0.2
0.56
1048
8610
(3001604) Monocytes [#/volume] in Blood
1180
9633
1.38
15.30
5.6
5.3
e9/l
0.7
0.6
3.86
1007
8181
(3022096) Basophils/100 leukocytes in Blood
1105
8928
1.39
15.24
5.9
5.6
%
0.6
0.6
0.81
1044
8242
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
58
181
3.25
15.18
1.3
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
672
5019
1.44
14.38
5.6
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
126
599
2.15
14.16
3.7
2.8
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
447
3086
1.53
14.15
3.6
3.8
u/l
231.9
245.3
1.15
424
2888
(3018010) Neutrophils/100 leukocytes in Blood
1120
9183
1.36
13.66
6.0
5.6
%
61.2
59.5
4.16
1055
8493
(3035637) Corticotropin [Mass/volume] in Plasma
60
204
2.98
13.63
1.3
1.5
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
84
350
2.44
12.88
5.3
6.2
mg/l
12.5
12.3
0.13
77
319
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
209
1222
1.77
12.79
1.8
1.8
ug/l
3.1
2.8
0.12
180
1053
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
63
238
2.68
11.83
2.6
2.0
u/field
4.5
1.8
0.81
27
85
(3029937) Albumin [Presence] in Urine by Test strip
698
5405
1.39
11.82
7.2
4.2
estimate
0.0
0.0
0.24
223
1691
(3042936) Bacteria identified in Isolate by Culture
450
3261
1.45
11.03
2.1
2.0
—
—
—
0
0
(3019225) pH of Specimen
336
2308
1.52
10.75
5.3
4.7
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
244
1565
1.61
10.55
4.1
2.1
nmol/l
416.9
375.2
2.39
231
1410
(3033658) Prothrombin time (PT) actual/Normal
669
5243
1.36
10.32
5.4
4.1
%
84.1
79.7
4.62
657
5105
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
42
138
3.07
10.20
2.5
1.8
u/field
5.7
2.5
1.38
28
95
(3019060) Gas panel - Arterial blood
274
1831
1.55
9.94
5.2
4.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
223
1423
1.61
9.85
4.3
3.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
193
1190
1.67
9.77
3.2
2.5
%
0.7
0.7
0.56
186
1147
(3018677) aPTT in Platelet poor plasma by Coagulation assay
511
3866
1.39
9.75
2.3
1.9
s
29.8
30.5
2.47
499
3742
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2039
18702
1.32
9.61
28.3
18.9
mg/l
37.9
29.7
19.89
1881
15668
(40758558) Short blood count panel - Blood
618
4836
1.35
9.53
8.6
6.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
59
250
2.39
8.83
2.6
2.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
35
113
3.12
8.79
1.3
1.3
iu/l
39.7
22.8
1.69
30
92
(3003694) ABO and Rh group [Type] in Blood
586
4622
1.34
8.47
1.3
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
503
3877
1.36
8.46
2.8
2.5
umol/l
11.2
11.9
1.40
465
3551
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
774
6348
1.30
8.45
2.4
2.2
mg/l
3.2
3.1
0.24
667
5322
(3009214) Lutropin [Units/volume] in Serum or Plasma
63
287
2.22
8.01
1.2
1.3
u/l
15.6
8.5
3.29
51
227
(3045414) Leukocytes [Presence] in Urine
139
832
1.70
7.91
2.7
2.0
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
107
595
1.83
7.83
3.0
2.6
%
17.1
15.7
2.99
77
313
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
241
1651
1.50
7.79
4.6
3.0
ml/min/173m2
57.0
58.7
0.33
128
723
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
449
3442
1.36
7.78
2.8
2.6
%
20.5
21.8
1.14
378
2901
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
344
2533
1.41
7.60
3.2
3.9
ug/l
52.5
27.3
0.32
289
2139
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
57
257
2.24
7.46
1.2
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
42
165
2.57
7.42
1.2
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
57
258
2.23
7.39
1.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
57
258
2.23
7.39
1.2
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
57
258
2.23
7.39
1.2
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
57
259
2.22
7.33
1.2
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
466
3625
1.34
7.31
2.8
2.5
g/l
2.2
2.2
0.06
427
3317
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
709
5849
1.28
7.23
3.6
3.1
u/l
35.0
37.2
0.37
672
5531
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
56
255
2.22
7.17
1.2
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
42
168
2.52
7.17
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
33
119
2.79
6.90
1.1
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
33
119
2.79
6.90
1.1
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
254
1811
1.44
6.72
2.6
2.3
u/l
39.5
37.0
0.26
215
1520
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1093
9544
1.24
6.70
2.4
2.2
pmol/l
91.0
90.7
0.08
689
5220
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
80
431
1.88
6.53
1.2
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
183
1243
1.50
6.20
5.8
4.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
914
7891
1.23
6.10
3.1
2.8
ug/l
172.2
181.6
0.53
841
7062
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
169
1138
1.52
5.98
2.2
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
150
995
1.54
5.70
3.1
2.7
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
101
609
1.68
5.68
2.4
2.2
g/l
129.7
127.7
0.31
79
453
(3008152) Bicarbonate [Moles/volume] in Arterial blood
233
1691
1.41
5.61
8.3
6.4
mmol/l
23.9
24.4
0.90
220
1582
(40761511) CBC panel - Blood by Automated count
2010
18856
1.22
5.52
28.0
18.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
100
607
1.67
5.50
5.0
5.2
mmol/l
2.3
2.6
0.55
63
406
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
531
4362
1.27
5.45
2.0
1.9
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
90
534
1.71
5.39
3.0
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
22
73
3.03
5.37
2.0
2.9
—
—
—
0
0
(4024509)
43
203
2.14
5.13
1.5
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
522
4314
1.26
5.06
3.7
3.1
mmol/l
2.5
2.5
4.58
448
3714
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
226
1666
1.39
4.99
1.8
1.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
75
434
1.75
4.94
2.2
3.9
%
1.5
1.5
0.03
53
314
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
122
800
1.55
4.93
1.3
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
152
1046
1.48
4.89
2.1
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
564
4720
1.24
4.88
4.4
4.3
ng/l
277.3
623.9
1.01
493
4202
(3008757) Leukocyte morphology finding [Identifier] in Blood
53
277
1.93
4.83
3.0
4.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
522
4337
1.25
4.82
8.0
4.3
kg/l
1.0
1.0
0.38
105
689
(1761482) Bacteria [#/volume] in Urine by Culture
116
756
1.56
4.82
6.4
4.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1837
17189
1.19
4.74
28.4
18.1
ml/min/173m2
66.2
70.4
14.66
1662
14320
(3019550) Sodium [Moles/volume] in Serum or Plasma
2085
19745
1.21
4.67
34.6
22.6
mmol/l
139.2
139.6
7.25
2040
19132
(1761868) Lipid panel - Serum or Plasma
402
4916
0.79
4.65
3.1
3.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2087
19775
1.21
4.61
34.7
22.8
mmol/l
4.1
4.0
10.92
2041
19130
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
156
1099
1.44
4.47
5.9
5.1
%
1.6
1.6
0.06
151
1030
(3009542) Hematocrit [Volume Fraction] of Blood
1693
15772
1.18
4.44
28.9
20.3
%
35.9
38.3
9.92
982
9256
(3007930) Methemoglobin/Hemoglobin.total in Blood
154
1084
1.44
4.44
6.0
5.2
%
0.9
0.9
0.41
149
1015
(3036603) Volume of Urine
30
130
2.32
4.43
1.3
1.5
ml
1889.9
1765.6
0.28
21
41
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
371
4554
0.79
4.42
1.6
1.6
mmol/l
1.4
1.3
1.26
312
3734
(3022217) INR in Platelet poor plasma by Coagulation assay
483
4020
1.24
4.37
29.8
31.2
inr
1.4
1.6
0.71
70
564
(3014051) Protein [Presence] in Urine by Test strip
77
468
1.66
4.29
3.4
2.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
38
185
2.07
4.25
1.2
1.2
u/l
45.2
62.2
1.35
26
122
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
54
298
1.83
4.21
1.2
1.3
—
—
—
0
0
(3010421) pH of Blood
106
700
1.53
4.20
4.9
4.9
ph
7.4
7.4
0.68
97
593
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1024
9209
1.17
4.02
4.7
4.5
ng/l
54.8
84.5
0.83
864
7421
(3021589) Normoblasts [#/volume] in Blood
929
8297
1.18
3.95
13.2
10.7
e9/l
0.0
0.0
0.49
748
6748
(3007853) Bacteria identified in Skin by Aerobe culture
321
2580
1.27
3.92
1.8
1.8
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
114
779
1.48
3.87
4.6
3.7
mmol/l
4.1
4.0
1.48
105
706
(3006462) Nitrate [Presence] in Urine
24
101
2.39
3.81
5.5
3.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
915
8186
1.17
3.78
3.1
3.3
ng/l
2502.7
2164.5
0.85
800
7180
(3013512) EKG study
763
6732
1.18
3.72
5.3
4.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
187
1408
1.35
3.68
1.5
1.7
g/l
1.8
1.5
3.15
163
1197
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
219
1690
1.32
3.65
3.8
3.9
ng/l
102.9
103.6
0.03
184
1438
(4211845)
25
110
2.28
3.61
5.4
3.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
48
269
1.80
3.61
2.4
4.0
%
64.1
58.8
0.84
30
159
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
50
285
1.77
3.56
1.3
1.7
iu/l
2.6
4.5
—
9
83
(3007461) Platelets [#/volume] in Blood
2100
20068
1.18
3.53
41.2
27.3
e9/l
241.6
229.4
11.65
2041
19351
(3024731) MCV [Entitic volume]
2100
20070
1.17
3.51
41.0
27.2
fl
91.9
92.1
0.68
2058
19565
(3026361) Erythrocytes [#/volume] in Blood
2100
20071
1.17
3.51
41.2
27.3
e12/l
4.2
4.4
29.96
2029
19256
(3000963) Hemoglobin [Mass/volume] in Blood
2100
20074
1.17
3.49
41.5
27.5
g/l
126.2
133.1
57.83
2052
19571
(3010813) Leukocytes [#/volume] in Blood
2100
20076
1.17
3.48
41.2
27.3
e9/l
7.7
7.1
14.01
2032
19260
(3035941) MCH [Entitic mass]
2099
20070
1.17
3.45
41.0
27.2
pg
30.3
30.6
9.56
2055
19564
(3045424) Erythrocytes [Presence] in Urine
50
289
1.74
3.41
1.6
1.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
97
663
1.48
3.33
2.0
2.3
ug/min
195.6
107.4
0.65
57
396
(40768800) Prostate Pathology biopsy report
52
850
0.60
3.28
1.1
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
215
1687
1.30
3.20
3.2
3.9
%
0.1
0.1
0.22
84
545
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
65
411
1.59
3.19
1.1
1.3
—
—
—
0
0
(3020891) Body temperature
140
1035
1.37
3.14
5.6
4.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
16
61
2.63
3.13
1.3
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
738
6576
1.16
3.12
4.5
4.0
ph
7.4
7.4
1.13
154
1282
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
14
50
2.81
3.08
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
118
852
1.40
3.05
2.6
2.9
g/l
0.4
0.3
0.46
61
362
(21494755) Public health laboratory ask at order entry panel
23
458
0.50
2.91
1.2
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
223
1789
1.27
2.82
3.1
3.9
%
0.9
0.9
0.04
86
585
(3047181) Lactate [Moles/volume] in Blood
110
800
1.39
2.76
6.9
6.1
mmol/l
1.4
1.4
0.10
97
706
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1169
10834
1.13
2.74
3.6
3.2
u/l
66.1
60.2
0.77
1062
9792
(3018572) Chloride [Moles/volume] in Blood
81
559
1.46
2.71
8.1
6.9
mmol/l
105.5
105.4
0.10
76
497
(3039000) Anion gap in Blood
81
559
1.46
2.71
8.1
6.9
mmol/l
11.3
11.3
0.05
76
497
(3023183) Ammonium ion [Moles/volume] in Plasma
76
520
1.47
2.66
2.0
2.3
umol/l
32.0
33.5
0.22
64
423
(3014271) Vancomycin [Susceptibility]
32
176
1.83
2.63
2.9
3.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
158
1225
1.31
2.62
3.2
3.4
e9/l
4.6
4.4
0.28
107
845
(3011648) Oxygen content in Venous blood
31
170
1.83
2.58
1.5
1.7
%
9.2
10.5
0.95
31
170
(40761536) Microorganisms panel - Urine sediment
215
1741
1.25
2.54
6.9
4.1
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
16
69
2.33
2.48
1.3
2.0
e6/l
1822.1
814.2
—
10
55
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
15
63
2.39
2.46
1.3
1.7
e6/l
1914.1
35502.5
—
7
39
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
122
924
1.33
2.41
2.4
2.2
ug/l
869.6
544.9
0.53
117
878
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
34
2.95
2.41
3.7
3.0
u/field
0.1
0.3
—
10
34
(3002179) Metamyelocytes/100 leukocytes in Blood
197
1590
1.26
2.40
3.0
3.8
%
0.6
0.6
0.13
64
411
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2020
19441
1.13
2.40
13.4
11.2
u/l
24.6
25.5
1.19
1940
18467
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
77
542
1.43
2.37
2.9
2.7
mg/l
2.1
1.8
0.97
68
465
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
34
198
1.73
2.35
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
74
1033
0.71
2.27
1.3
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
117
891
1.33
2.25
2.6
3.1
u/ml
816.5
5792.3
0.89
104
757
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
54
358
1.52
2.25
1.1
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
77
548
1.42
2.24
1.5
1.5
ug/g
231.0
257.3
0.56
46
347
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
20
101
1.99
2.15
5.5
5.7
u/ml
17.4
26.4
—
7
27
(3044927) Protein electrophoresis panel - Urine
48
316
1.53
2.08
1.1
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
280
2382
1.19
2.08
2.9
2.7
umol/l
11.2
10.3
0.16
236
2111
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
49
325
1.52
2.06
2.5
2.2
mg/l
42.1
24.1
—
10
79
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
344
2984
1.17
2.04
1.9
1.8
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
19
97
1.96
2.00
1.2
1.1
u/l
13.9
37.4
2.22
14
70
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
19
97
1.96
2.00
1.2
1.1
u/l
79.4
102.8
0.64
14
72
(3013707) Erythrocyte sedimentation rate by Westergren method
1488
14157
1.11
1.97
4.3
4.1
mm/h
18.6
14.9
10.28
1347
12838
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
86
640
1.35
1.96
1.6
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
27
157
1.73
1.92
7.3
15.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
113
879
1.30
1.91
1.2
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
50
0.00
1.88
0.0
1.5
—
1.1
—
0
45
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
287
2474
1.18
1.86
2.3
2.5
ug/l
4.6
7.2
3.71
236
2109
(3033705) Calcium.ionized [Moles/volume] in Venous blood
55
384
1.44
1.83
3.2
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
1449
13801
1.10
1.83
4.7
4.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
45
302
1.50
1.82
4.3
3.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
341
2988
1.16
1.80
1.9
1.8
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
187
1555
1.22
1.80
3.2
3.9
%
0.1
0.4
0.85
71
443
(3020630) Protein [Mass/volume] in Serum or Plasma
266
2287
1.18
1.78
2.2
2.5
g/l
65.5
65.9
0.31
236
2051
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
36
232
1.56
1.76
1.4
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
173
1435
1.22
1.72
1.5
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
292
2539
1.17
1.71
2.1
2.4
e9/l
74.1
66.4
0.75
238
1972
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
152
1246
1.23
1.69
2.6
2.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
92
712
1.30
1.65
1.4
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
94
731
1.30
1.63
3.7
3.3
pmol/l
4.3
4.3
0.08
87
621
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1691
17526
0.91
1.61
4.4
4.8
mmol/l
4.2
4.2
0.71
1498
15757
(3019309) Folate [Moles/volume] in Red Blood Cells
595
5451
1.12
1.59
1.8
1.8
nmol/l
1109.7
1162.5
0.71
439
4057
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
85
655
1.31
1.59
1.2
1.1
iu/ml
109.8
128.0
0.13
17
224
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
742
6881
1.11
1.57
2.1
2.2
u/l
206.7
246.8
0.89
695
6399
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1672
17326
0.92
1.56
4.3
4.7
mmol/l
1.3
1.4
1.84
1472
15415
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
92
1.85
1.56
1.2
1.1
u/ml
1.0
1.3
—
9
36
(3017143) Hepatitis C virus Ab [Presence] in Serum
167
1403
1.20
1.49
1.5
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
422
3808
1.13
1.47
4.4
4.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
979
10355
0.92
1.43
4.2
4.8
%
21.1
22.2
1.66
484
5613
(3026493) Urate [Moles/volume] in Serum or Plasma
632
5842
1.10
1.43
2.9
3.0
umol/l
7140.6
7030.3
0.02
543
4907
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
23
141
1.64
1.41
2.2
2.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1349
12908
1.09
1.40
4.8
5.6
ug/l
3.1
4.9
1.85
1124
11361
(3009445) Proteinase 3 Ab [Units/volume] in Serum
114
928
1.24
1.40
1.5
1.6
u/ml
25.6
23.3
—
5
26
(3005570) Glucose [Moles/volume] in Urine
33
222
1.49
1.38
1.8
2.0
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
5
17
2.94
1.36
1.0
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
15
82
1.83
1.35
1.1
1.0
u/ml
1.1
0.9
—
7
33
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1628
16826
0.92
1.31
4.0
4.3
mmol/l
1.4
1.3
6.17
1414
14831
(3003888) Timothy IgE Ab [Units/volume] in Serum
15
83
1.81
1.31
1.1
1.0
u/ml
3.1
4.4
—
9
34
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
196
2260
0.86
1.30
1.2
1.2
u/ml
47.7
12.8
0.60
55
772
(3025315) Body weight
5
18
2.78
1.28
5.6
2.9
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
560
5180
1.10
1.25
1.7
1.8
pmol/l
29273926.5
18945257.5
0.14
468
4170
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
45
329
1.37
1.24
3.8
3.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
46
339
1.36
1.21
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
19
116
1.64
1.21
1.4
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
282
2518
1.13
1.20
5.6
4.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
287
2568
1.13
1.18
4.3
4.8
%
32.6
33.0
0.20
188
1656
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
126
0.48
1.16
1.0
1.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
10
50
2.00
1.16
1.5
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1763
18123
0.93
1.16
4.9
5.4
mmol/l
2.4
2.4
1.29
1554
16189
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
129
0.46
1.16
2.0
2.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
192
1677
1.16
1.13
1.4
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
17
271
0.62
1.13
1.0
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
32
225
1.43
1.12
1.4
1.7
mu/l
348.3
280.8
0.74
32
211
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
215
1898
1.14
1.10
4.7
4.0
mmol/l
1.2
1.2
0.28
196
1656
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
139
0.50
1.09
1.1
1.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1507
14577
1.07
1.08
34.0
22.7
%
14.3
14.0
10.78
1471
14170
(3027456) Digoxin [Moles/volume] in Serum or Plasma
54
693
0.77
1.08
2.9
3.1
nmol/l
0.8
0.8
0.45
37
518
(3024980) IgG subclass 4 [Mass/volume] in Serum
32
227
1.41
1.07
2.1
1.4
g/l
0.9
0.9
0.08
23
175
(40768793) Breast Pathology biopsy report
9
166
0.54
1.07
1.3
1.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
23
153
1.51
1.06
2.3
2.1
e9/l
1.2
1.0
0.33
14
89
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
33
2.12
1.05
2.6
1.6
ng/l
198.7
196.4
—
7
33
(3000093) Morphology [Interpretation] in Blood Narrative
35
255
1.38
1.02
1.1
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
869
8259
1.07
1.02
2.3
2.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
32
230
1.40
1.01
1.9
2.2
ml
753.8
639.7
0.60
17
137
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
19
123
1.55
0.99
2.2
2.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
60
477
1.26
0.97
1.5
1.6
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
7
36
1.95
0.97
12.1
17.5
nmol/l
1063.3
1375.9
—
7
36
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
29
208
1.40
0.94
1.0
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
24
166
1.45
0.94
1.3
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
16
245
0.65
0.93
1.4
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
12
70
1.72
0.92
1.5
2.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
9
52
1.73
0.92
1.4
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
407
0.73
0.91
1.9
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
171
0.58
0.91
1.7
2.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
118
1.53
0.90
1.4
1.6
u/l
4.3
9.2
—
6
60
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
48
376
1.28
0.89
3.0
3.8
%
62.7
59.7
0.69
48
376
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
5
102
0.49
0.89
1.2
1.1
mg/l
30.4
46.4
—
5
84
(3026389) Candida sp identified in Specimen by Organism specific culture
30
219
1.37
0.89
1.6
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
214
2379
0.89
0.89
1.2
1.2
iu/ml
38.2
39.6
0.04
68
720
(3035320) C reactive protein [Mass/volume] in Body fluid
20
135
1.48
0.89
4.1
2.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
433
4030
1.09
0.88
1.7
1.7
mg/l
2.0
1.6
1.08
368
3210
(3042631) Mycobacterium sp identified in Specimen
52
414
1.26
0.86
2.7
2.7
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
31
1.94
0.84
1.8
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
20
137
1.46
0.84
4.0
3.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
163
1834
0.88
0.84
1.9
2.1
nmol/l
10.7
11.8
0.88
133
1553
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
96
818
1.18
0.83
1.6
2.3
g/l
36.6
36.8
0.08
76
686
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
72
598
1.21
0.82
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
72
598
1.21
0.82
1.7
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
109
940
1.17
0.82
2.4
3.3
mg/l
71.4
62.7
0.24
89
761
(4281824)
17
113
1.51
0.82
1.1
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
267
2917
0.91
0.82
1.2
1.2
u/ml
3.5
1.9
0.37
55
717
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
32
1.88
0.81
8.7
12.9
mmol/l
5.3
5.9
—
6
32
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
32
1.88
0.81
1.2
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
12
73
1.65
0.81
8.5
7.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
85
720
1.19
0.80
1.6
1.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
10
58
1.73
0.79
2.0
2.3
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
33
1.82
0.79
1.5
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
11
175
0.63
0.78
1.0
1.5
—
1640.0
—
0
6
(3019832) Treponema pallidum Ab [Presence] in Serum
36
462
0.78
0.78
1.2
1.3
—
—
—
0
0
(4062490)
21
148
1.42
0.77
1.5
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
5
100
0.50
0.77
1.2
1.0
mg/l
225.8
290.1
—
5
86
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
157
1.40
0.76
1.1
1.2
miu/ml
270.8
128.2
—
5
35
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
34
1.77
0.76
1.7
2.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
59
1.70
0.75
2.1
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
227
2067
1.11
0.75
1.3
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
183
1.37
0.75
1.2
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
9
53
1.70
0.75
2.2
2.5
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
108
939
1.16
0.75
2.5
3.3
mg/l
44.4
68.1
0.85
88
767
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
696
7291
0.94
0.74
2.9
3.3
ug/l
0.8
0.8
0.54
480
5306
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
5
24
2.08
0.74
1.2
1.9
ug/l
6.1
2.1
—
5
9
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
255
0.70
0.74
1.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
108
1.48
0.73
1.8
2.2
%
17.8
16.2
—
6
44
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
1065
1.14
0.72
2.0
2.4
g/l
4.0
3.8
0.64
82
747
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
1067
1.14
0.70
2.0
2.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
111
973
1.15
0.70
2.1
2.5
g/l
3.2
3.1
0.40
83
760
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
114
1002
1.14
0.69
2.0
2.4
g/l
9.8
10.5
0.91
91
841
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
121
1068
1.14
0.69
2.0
2.4
g/l
7.4
7.4
0.07
82
771
(3014765) Yersinia sp identified in Stool by Organism specific culture
60
500
1.20
0.69
1.3
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
365
3413
1.08
0.69
2.2
2.3
%
1.9
1.7
1.74
312
2969
(3020682) Albumin/Creatinine [Ratio] in Urine
756
7245
1.06
0.69
3.9
4.0
mg/mmol
16.1
10.2
2.55
544
4806
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1771
18050
0.95
0.67
5.1
5.2
mmol/l
6.3
6.2
1.42
1571
15859
(3000285) Sodium [Moles/volume] in Blood
7
43
1.63
0.66
1.0
1.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
46
559
0.82
0.65
1.1
1.1
—
130.1
—
0
8
(3014891) Appearance of Pleural fluid
10
62
1.61
0.65
1.9
1.4
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
146
1.37
0.63
1.5
1.1
g/l
2.9
2.9
0.01
12
110
(3027135) IgG subclass 1 [Mass/volume] in Serum
20
146
1.37
0.63
1.5
1.1
g/l
6.0
7.4
0.82
12
109
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
146
1.37
0.63
1.5
1.1
g/l
0.3
0.4
0.55
12
109
(3051387) C reactive protein [Mass/volume] in Capillary blood
63
535
1.18
0.61
3.6
3.6
mg/l
34.4
32.4
0.17
38
359
(3035880) pH of Pleural fluid
14
199
0.70
0.61
1.6
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
18
130
1.39
0.61
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
104
920
1.14
0.60
1.2
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
20
0.00
0.60
0.0
1.2
—
2.0
—
0
20
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
8
51
1.57
0.60
3.0
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
9
141
0.64
0.60
1.0
1.6
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
208
1914
1.09
0.59
2.0
2.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
33
263
1.26
0.59
1.8
1.5
%
64.8
66.9
0.13
23
170
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
8
52
1.54
0.59
1.1
1.2
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
56
660
0.85
0.59
2.0
1.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
22
288
0.76
0.59
1.8
1.6
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
7
112
0.62
0.58
1.4
1.5
umol/l
13.7
16.3
—
7
102
(3037522) Nuclear Ab [Titer] in Serum
213
1968
1.09
0.56
1.3
1.3
titre
364.7
438.2
0.52
43
436
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
98
1.43
0.56
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
59
504
1.17
0.55
1.3
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
90
0.55
0.55
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
27
212
1.28
0.55
1.3
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
713
6866
1.05
0.55
3.1
3.2
mmol/l
7.0
7.6
4.42
575
5585
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
58
496
1.17
0.54
1.3
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
60
1.50
0.54
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
44
367
1.20
0.54
1.1
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
14
99
1.42
0.54
2.4
2.0
e9/l
0.3
0.2
0.76
14
88
(3012516) Albumin [Mass/volume] in Urine
708
6821
1.05
0.54
3.3
3.3
mg/l
461.7
255.3
0.64
522
4583
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
48
404
1.19
0.54
1.1
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
19
143
1.33
0.52
1.2
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
9
63
1.43
0.52
1.0
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
96
0.62
0.52
1.3
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
40
1.50
0.51
1.3
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
179
1.29
0.51
1.2
1.3
nmol/l
—
—
—
0
0
(40768443) Skin Pathology biopsy report
98
876
1.12
0.51
1.3
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
109
1.38
0.50
1.9
2.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
57
491
1.16
0.50
2.6
3.3
u/ml
144.3
1191.8
1.16
51
456
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
17
224
0.76
0.49
1.5
1.6
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
27
216
1.25
0.49
1.4
1.3
mu/l
44.0
87.7
1.37
22
187
(4010399)
146
1338
1.10
0.48
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
19
145
1.31
0.48
1.3
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
46
1.52
0.48
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
70
615
1.14
0.48
1.5
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
23
181
1.27
0.48
1.0
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
291
2746
1.07
0.47
13.0
8.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
21
266
0.79
0.46
1.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
5
82
0.61
0.45
3.2
1.9
u/l
18.8
45.0
—
5
75
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
83
742
1.12
0.45
1.8
1.7
u/l
33.9
37.1
0.61
69
619
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
52
450
1.16
0.44
1.1
1.2
u/l
25.1
49.0
1.79
44
386
(3040151) Glucose [Moles/volume] in Capillary blood
41
349
1.18
0.43
4.0
7.6
mmol/l
7.8
7.7
0.09
36
284
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
14
185
0.76
0.43
1.1
1.2
u/ml
7.3
5.3
—
6
91
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
98
888
1.11
0.42
1.8
2.6
g/l
0.7
1.3
1.00
79
743
(3006270) Folate [Moles/volume] in Blood
28
230
1.22
0.42
1.2
1.3
nmol/l
295.5
313.3
0.17
20
172
(3028026) IgM [Mass/volume] in Serum or Plasma
118
1080
1.10
0.42
1.6
1.9
g/l
1.5
1.5
0.03
108
971
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
12
162
0.74
0.42
1.0
1.0
ng/l
582.5
629.0
—
6
96
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
12
162
0.74
0.42
1.0
1.0
ng/l
44.7
41.8
—
7
98
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
12
162
0.74
0.42
1.0
1.0
ng/l
372.7
298.5
—
7
100
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
27
222
1.22
0.41
1.3
1.6
—
—
—
0
0
(1002224) Polysomnography panel
31
369
0.84
0.40
1.0
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1272
12959
0.97
0.40
3.6
3.4
pmol/l
15.1
15.1
0.05
1116
11333
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
18
0.00
0.40
0.0
6.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
12
88
1.36
0.40
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
102
0.69
0.39
1.0
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
35
1.43
0.39
1.8
2.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
47
409
1.15
0.39
1.4
1.3
mmol/l
55.7
64.3
0.80
37
320
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
52
456
1.14
0.39
1.2
1.3
g/l
0.2
0.2
0.17
43
433
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
10
137
0.73
0.39
1.1
1.1
mmol/l
2.7
2.1
—
10
123
(3005719) IgG [Mass/volume] in Serum or Plasma
147
1366
1.08
0.38
2.2
2.7
g/l
10.3
10.9
1.02
135
1236
(3044941) Cell count panel - Synovial fluid
30
356
0.84
0.38
1.4
1.4
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
19
151
1.26
0.38
2.2
2.2
ug/min
11.8
79.7
—
5
39
(3000012) Reticulocyte production index
12
159
0.75
0.38
1.1
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
602
5835
1.04
0.37
1.6
1.6
nmol/l
18.9
19.2
0.17
524
4950
(40765096) Chromosome analysis panel by Banding
9
71
1.27
0.36
1.6
1.1
—
—
—
0
0
(4146454)
32
272
1.18
0.36
2.0
2.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
42
1.43
0.35
1.3
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
73
1.37
0.34
2.7
2.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
44
1.36
0.34
2.0
1.3
ug/l
8.0
10.1
—
6
44
(21494434) Karyotype in Bone marrow
21
254
0.83
0.34
1.1
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
144
1538
0.93
0.33
1.5
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
40
349
1.15
0.33
1.8
1.6
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
188
0.80
0.33
1.1
1.2
u/ml
1.8
3.4
—
6
70
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1726
17457
0.97
0.32
6.7
6.8
mmol/mol
42.6
41.6
2.46
1552
15729
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
7
100
0.70
0.30
1.0
1.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
49
438
1.12
0.30
1.3
1.5
e6/l
1073.4
1900.8
1.41
34
311
(3052851) Hemolysis interference index of Serum or Plasma
77
706
1.09
0.30
5.0
3.6
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
21
175
1.20
0.30
3.6
3.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
15
120
1.25
0.30
1.1
1.2
iu/ml
—
3.7
—
0
6
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
93
1.29
0.30
1.2
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
47
525
0.89
0.29
1.1
1.1
—
1.9
—
0
7
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
130
0.77
0.29
1.0
1.2
—
—
—
0
0
(4034850)
58
639
0.91
0.29
18.6
13.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
28
241
1.16
0.29
1.0
1.1
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
30
260
1.16
0.28
1.2
1.3
u/ml
122.8
125.9
—
5
45
(3007164) IgA [Mass/volume] in Serum or Plasma
259
2700
0.96
0.28
1.4
1.5
g/l
3.0
2.9
0.10
156
1568
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
56
509
1.10
0.27
1.6
1.6
iu/ml
1.0
25.4
1.15
19
129
(3028308) Erythrocytes [#/volume] in Pleural fluid
45
404
1.12
0.26
1.3
1.4
e6/l
16883.7
79840.5
2.57
30
242
(3004716) Salmonella sp identified in Stool by Organism specific culture
65
596
1.09
0.26
1.3
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
18
150
1.20
0.26
1.2
1.1
—
59.0
—
0
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
27
310
0.87
0.26
1.1
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
44
396
1.11
0.25
1.3
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
42
377
1.12
0.25
1.2
1.2
u/ml
5.0
3.9
—
6
51
(21494890) Protein electrophoresis panel - 24 hour Urine
32
282
1.14
0.25
1.7
2.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
52
473
1.10
0.25
1.2
1.3
g/l
1.1
1.1
0.11
44
447
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
77
714
1.08
0.25
1.7
2.5
g/l
0.0
0.0
0.00
70
647
(3012565) Volume of 24 hour Urine
13
105
1.24
0.24
1.7
2.6
ml
2357.1
1964.5
—
7
88
(3051611) Lipemic interference index of Serum or Plasma
27
236
1.15
0.24
4.1
3.7
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
83
0.72
0.24
1.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
13
158
0.82
0.23
1.5
2.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
244
2530
0.96
0.23
2.9
3.1
ng/l
254.3
293.7
0.79
222
2319
(3007566) Smooth muscle Ab [Titer] in Serum
47
428
1.10
0.23
1.3
1.1
titre
72.0
95.4
—
5
24
(3048879) Bone marrow aspiration report
11
88
1.25
0.22
1.1
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
91
0.77
0.22
1.0
1.1
—
—
—
0
0
(4133840)
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
40
1.25
0.22
1.2
1.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
30
336
0.89
0.21
1.0
1.1
—
15.9
—
0
18
(3016018) Differential panel - Cerebral spinal fluid
14
167
0.84
0.21
1.5
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3024316) Viscosity of Plasma
0
11
0.00
0.21
0.0
1.4
—
1.7
—
0
5
(44806071)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
0
12
0.00
0.21
0.0
1.1
—
5.4
—
0
5
(3003338) MCHC [Mass/volume]
1462
14473
1.02
0.21
37.1
24.9
g/l
329.6
331.8
15.40
1438
14246
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1631
16451
0.98
0.21
4.5
4.3
mu/l
2.0
2.1
2.69
1449
14480
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
13
0.00
0.21
0.0
1.2
—
393.5
—
0
13
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
38
418
0.91
0.20
1.4
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
187
0.85
0.20
2.0
1.6
—
—
—
0
0
(4094501)
52
480
1.08
0.20
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
55
593
0.93
0.20
1.5
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
55
510
1.08
0.19
1.5
1.5
g/l
30.9
30.5
0.08
46
443
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
6
51
1.18
0.19
1.5
2.1
%
21.8
31.8
—
6
45
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
90
1.22
0.19
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
90
1.22
0.19
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
23
203
1.13
0.19
1.0
1.3
pmol/l
264.1
252.1
0.06
15
156
(3010144) Erythrocytes [#/volume] in Synovial fluid
24
213
1.13
0.18
1.7
1.3
e6/l
20090.4
156750.4
1.73
19
149
(3015171) Extractable nuclear Ab [Units/volume] in Serum
48
518
0.93
0.18
1.3
1.2
u/ml
0.3
1.2
—
5
48
(3023419) Bacteria identified in Sputum by Culture
37
338
1.10
0.18
2.1
2.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
44
406
1.08
0.17
1.6
1.5
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
119
1.18
0.17
2.1
2.0
e6/l
323.8
608.6
—
8
48
(36660697) Celiac disease serology panel - Serum
96
1008
0.95
0.17
1.2
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
30
272
1.10
0.17
1.3
1.3
u/l
9.4
15.1
1.94
30
248
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
82
777
1.06
0.17
1.7
2.4
g/l
0.0
0.1
2.07
75
696
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
70
0.71
0.16
1.2
1.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
76
719
1.06
0.16
2.7
3.4
—
—
—
0
0
(4306422)
14
162
0.86
0.16
1.1
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
149
1545
0.96
0.16
2.3
2.2
ug/g
178.7
179.6
0.01
122
1199
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
77
730
1.06
0.16
1.7
2.4
g/l
0.0
0.0
0.79
70
651
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
151
0.86
0.15
1.7
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
73
770
0.95
0.15
1.2
1.3
u/ml
517.8
269.6
0.60
68
701
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
80
0.75
0.15
1.2
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
44
472
0.93
0.15
1.2
1.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
24
217
1.11
0.14
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
93
1.18
0.14
1.2
1.2
—
—
—
0
0
(44790048)
27
246
1.10
0.14
1.5
1.5
—
—
—
0
0
(44790049)
27
246
1.10
0.14
1.5
1.5
—
—
—
0
0
(44806118)
27
246
1.10
0.14
1.5
1.5
—
—
—
0
0
(44790047)
27
246
1.10
0.14
1.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
40
372
1.08
0.14
1.4
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
23
208
1.11
0.14
1.2
1.3
mosm/kgh2o
284.7
277.9
0.64
18
144
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
13
149
0.87
0.13
1.7
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
27
247
1.09
0.13
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
142
1466
0.97
0.13
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
9
106
0.85
0.13
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
9
106
0.85
0.13
1.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
52
550
0.94
0.13
1.1
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
116
0.86
0.12
1.2
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
35
374
0.93
0.11
1.4
1.7
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
11
95
1.16
0.11
1.9
3.6
%
57.4
53.8
0.29
11
89
(4268621)
11
126
0.87
0.11
2.1
2.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
14
124
1.13
0.11
1.1
1.2
mmol/l
13.1
11.8
—
5
41
(40768806) Pleura Pathology biopsy report
42
396
1.06
0.11
1.6
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
15
167
0.90
0.10
1.1
1.2
—
62.8
—
0
9
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
352
0.94
0.10
1.3
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
96
1.15
0.10
1.1
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
212
1.09
0.10
1.3
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
212
1.09
0.10
1.3
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
212
1.09
0.10
1.3
1.5
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
44
1.14
0.10
2.8
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
47
1.06
0.09
1.0
1.1
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
47
1.06
0.09
2.6
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
5
48
1.04
0.09
1.0
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
34
360
0.94
0.09
1.3
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
20
184
1.09
0.09
2.2
2.5
ph
7.4
7.4
—
7
68
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
134
0.89
0.08
1.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
36
341
1.06
0.08
1.6
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
57
1.05
0.08
1.3
1.2
—
—
—
0
0
(44806420)
12
107
1.12
0.08
2.3
2.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
153
1498
1.02
0.08
1.6
1.7
%
1.7
1.7
0.20
125
1241
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
23
246
0.93
0.08
1.2
1.2
u/ml
201.4
306.7
1.34
12
137
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
14
127
1.10
0.07
1.1
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
71
0.84
0.07
4.2
1.3
ug/l
31.2
9.7
—
6
61
(3013166) Neutrophils/100 leukocytes in Synovial fluid
6
73
0.82
0.07
2.0
1.2
%
86.4
67.2
—
6
62
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
174
0.92
0.07
1.7
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
74
0.81
0.07
3.5
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
50
520
0.96
0.07
1.6
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
74
1.08
0.07
1.1
1.7
—
—
—
0
0
(44813793)
8
74
1.08
0.07
1.3
1.0
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
77
1.04
0.07
3.1
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
80
0.87
0.07
1.7
1.8
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
8
92
0.87
0.06
2.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
93
0.86
0.06
2.3
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
50
482
1.04
0.06
1.5
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
454
1.04
0.05
1.1
1.2
—
—
—
0
0
(3000492) Spirometry study
144
1417
1.02
0.05
1.5
1.5
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
364
0.96
0.05
1.3
1.3
e6/l
22.5
33.5
0.24
24
290
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
364
0.96
0.05
1.5
1.4
e6/l
1347.1
814.7
0.24
27
301
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
384
0.96
0.05
5.8
4.7
iu/ml
1700.4
5182.3
—
7
50
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
191
0.94
0.04
1.2
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
150
1.07
0.04
1.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
17
160
1.06
0.04
2.1
1.9
min
506.0
492.5
—
9
111
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
12
129
0.93
0.03
1.2
1.2
—
34.3
—
0
6
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
34
329
1.03
0.03
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
141
1.06
0.03
1.6
3.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
16
151
1.06
0.03
1.2
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
161
1.06
0.03
1.1
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
92
1.09
0.03
1.3
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
34
330
1.03
0.03
1.3
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
742
7396
1.00
0.03
2.1
2.1
nmol/l
77.6
78.0
0.14
653
6346
(40768797) Stomach Pathology biopsy report
258
2594
0.99
0.02
1.2
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
42
411
1.02
0.02
1.6
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
10
93
1.08
0.02
1.4
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
10
93
1.08
0.02
1.4
1.6
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
103
1.07
0.02
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
103
1.07
0.02
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
103
1.07
0.02
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
63
639
0.99
0.02
1.4
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
34
348
0.98
0.01
1.4
1.3
u/l
325.9
431.6
0.36
34
327
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
55
558
0.99
0.01
1.5
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
25
257
0.97
0.01
1.1
1.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
427
0.98
0.01
1.5
1.6
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
54
547
0.99
0.01
1.7
1.6
e6/l
32860.0
15804.5
0.79
43
381
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
94
1.06
0.01
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
104
1.06
0.00
1.7
1.2
nmol/l
139.1
133.8
0.20
11
104
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
114
1.05
0.00
1.1
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
134
1.04
0.00
1.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
134
1.04
0.00
1.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
16
154
1.04
0.00
1.7
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
346
0.98
0.00
1.6
1.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
61
616
0.99
0.00
1.2
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
231
1.00
0.00
1.1
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
201
0.99
0.00
2.1
1.4
%
15.1
20.7
0.80
15
126
(3045788) Cell count panel - Pleural fluid
35
346
1.01
0.00
1.5
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
33
332
0.99
0.00
1.2
1.2
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
31
309
1.00
0.00
1.2
1.3
—
18.8
—
0
8
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
309
1.00
0.00
1.2
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
269
1.00
0.00
1.2
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
130
1.00
0.00
1.3
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
101
0.99
0.00
1.1
1.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
144
0.97
0.00
1.4
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
96
1.04
0.00
1.4
1.6
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
26
262
0.99
0.00
3.8
3.9
umol/l
366.4
328.5
0.81
20
222
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
48
475
1.01
0.00
1.5
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
30
297
1.01
0.00
1.5
1.3
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
17
174
0.98
0.00
1.2
1.4
—
192.8
—
0
25
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
17
174
0.98
0.00
1.5
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
10
99
1.01
0.00
1.2
1.2
u/l
203.9
396.4
—
10
91
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
13
125
1.04
0.00
1.5
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
223
2225
1.00
0.00
1.4
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
104
0.96
0.00
1.1
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
25
251
1.00
0.00
1.5
1.4
u/l
13.2
13.5
0.09
25
233
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
128
1.02
0.00
1.1
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
8.6
—
0
5
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
98
0.92
0.00
2.1
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
36.6
—
0
5
(3052592) Norovirus Ag [Presence] in Stool
5
53
0.94
0.00
1.2
1.4
—
—
—
0
0
(3039528) Macrophages/100 leukocytes in Pleural fluid by Manual count
0
5
0.00
0.00
0.0
3.8
—
29.8
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
81
0.99
0.00
2.3
1.4
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
81
0.99
0.00
2.3
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
222.0
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
4.5
—
0
8
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
1.7
—
0
6
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
92
0.98
0.00
2.7
2.1
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
97
0.93
0.00
2.1
1.2
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
5
55
0.91
0.00
39.0
32.4
ug/l
7.1
6.8
—
5
49
(3030313) Adrenal Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
92
0.98
0.00
2.7
2.1
—
—
—
0
0
(3011048) Pyruvate [Moles/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
90.6
—
0
7
(3010375) cycloSPORINE [Mass/volume] in Blood
6
68
0.88
0.00
43.7
26.5
ug/l
130.3
118.7
—
6
57
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
5
57
0.88
0.00
4.2
2.8
ml/dl
13.1
14.7
—
5
52
(4015189)
8
79
1.01
0.00
1.5
2.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
95
0.95
0.00
2.1
1.2
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
7
76
0.92
0.00
1.1
1.2
iu/ml
84.3
247.1
—
7
76
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
205.5
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
31.3
—
0
8
(3027944) Amphetamines [Presence] in Urine
9
95
0.95
0.00
2.1
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
7
69
1.01
0.00
2.7
1.4
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
7
77
0.91
0.00
1.0
1.2
%
—
58.3
—
0
10
(3011288) Drugs identified in Urine by Screen method
7
70
1.00
0.00
3.0
1.4
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BLADDER – Malignant neoplasm of bladder
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).